Clinical Trial Update: Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients

View source ↗

Summary

A completed clinical trial evaluating whether interleukin-6 is linked to thyroid dysfunction in patients with chronic kidney disease on hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Thyroid Disorders

Snippet

Sponsor: Dr. Soetomo General Hospital | Conditions: Chronic Kidney Disease on Hemodialysis, Thyroid Gland Disease | Status: COMPLETED